Robert ORR,Kathryn Emily Colombo PUGH,Matthew Jarud SHAFFER,Brent Antone UHRIG,Edward Dennis LACHAPELLE,Charlie Michael MCLAUGHLIN
申请号:
US16848676
公开号:
US20200237756A1
申请日:
2020.04.14
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present disclosure relates to pharmaceutical compositions comprising N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)-benzamide and a polymer, dosage forms comprising the formulation and methods of treating subjects having cancer.